Dr. Mary Scollay

Drug Testing Under HISA: When Uniformity and Variability Collide

From an altitude of 10,000 feet, the Horseracing Integrity and Safety Act (HISA)'s mandated goal is a simple two-pronged affair. Uniformity in welfare and safety. Uniformity in drug testing. Over the past few months, the Horseracing Integrity and Welfare Unit (HIWU)--HISA's enforcement arm--has made several announcements that have peeled the curtain back on just how difficult the second part of that equation will be to accomplish. Internal reviews of the six HIWU-contracted laboratories uncovered different limits of detection in blood for diabetes drug Metformin and for benzoylecgonine (BZE), a metabolite...

[ Read More ]
Given 22-Month Suspension From HIWU, Trainer Poole Calls Process A 'Joke'

When two members of Gulfstream Park's security team and a veterinarian descended on his barn on the morning of June 2, the 62-year-old trainer Jeff Poole didn't think he had anything to worry about. According to the Jockey Club's Thoroughbred Regulatory Rulings website, Poole, who has been training since 1989, had never had a violation of any kind. And his recent record--he had won 11 races combined since 2021--hardly suggested that he was a trainer who was taking an edge. Even when investigators found in his office a tube of...

[ Read More ]
Dr. Mary Scollay Named Horseracing Integrity & Welfare Unit Chief of Science

The Horseracing Integrity & Welfare Unit (HIWU), which was established by Drug Free Sport International to administer the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program, has named Dr. Mary Scollay as its chief of science. In this role, which she commences Oct. 10, Scollay will oversee HIWU's Science Department, including the HISA Equine Analytical Laboratory accreditation program, and education efforts ahead of the ADMC Program launch in January 2023. She will also prioritize research development into Prohibited Substances while engaging with veterinary scientists, pharmacologists, and...

[ Read More ]
Racing Medication and Testing Consortium to Fund Postdoctoral Fellowship

The Racing Medication & Testing Consortium (RMTC) has announced that it will fund the research proposal, "Detection of Bisphosphonates Using Metabolomics," submitted by Dr. Bethany Keen at the University of Pennsylvania's Equine Testing and Research Laboratory. Dr. Keen's research to date has been conducted in Australia and focused on equine anti-doping, analytical chemistry, and statistics. Metabolomics is an emerging field in doping control and represents a novel testing approach that identifies cellular effects unique to a class of drugs rather than identifying the specific molecule responsible for those effects. "The...

[ Read More ]
RMTC Announces Post-Doctorate Fellowship Program

Edited Press Release Racing Medication and Testing Consortium (RMTC) has announced their support of post-doctoral training by funding a Fellowship Program beginning in 2022. The need for establishing such a program is two-fold:   To promote a sustained research program with a core focus on anti-doping, to include topics related to drug testing, development of new analytical methods with application to racing chemistry, pharmacokinetics/pharmacodynamics, forensic toxicology, or other related disciplines. The future of horseracing's anti-doping programs requires mentoring young scientists to become researchers, racing laboratory directors, and industry leaders. Innovation...

[ Read More ]

Never miss another story from the TDN

Click Here to sign up for a free subscription.